Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-097753
Filing Date
2023-09-01
Accepted
2023-09-01 17:12:32
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2325187d1_s3.htm S-3 357078
2 EXHIBIT 4.12 tm2325187d1_ex4-12.htm EX-4.12 352969
3 EXHIBIT 4.13 tm2325187d1_ex4-13.htm EX-4.13 394004
4 EXHIBIT 5.1 tm2325187d1_ex5-1.htm EX-5.1 37771
5 EXHIBIT 23.1 tm2325187d1_ex23-1.htm EX-23.1 1821
6 EX-FILING FEES tm2325187d1_ex-filingfees.htm EX-FILING FEES 32371
7 GRAPHIC tm2325187d1_ex5-1img01.jpg GRAPHIC 2781
8 GRAPHIC tm2325187d1_ex5-1img02.jpg GRAPHIC 1551
  Complete submission text file 0001104659-23-097753.txt   1183402
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274328 | Film No.: 231233358
SIC: 2834 Pharmaceutical Preparations